Wafergen BioSystems Raises $1.3M in Stock Placement | GenomeWeb
NEW YORK (GenomeWeb News) — Wafergen BioSystems said today it has landed $1.3 million in a private placement of common stock.
 
Wafergen last week said it had gained $10.7 million in financing as it completed a reverse merger with a shell company.
  
The company said last week it plans to use the proceeds from the investment for corporate infrastructure and product offerings, such as the company’s SmartChip system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.